National Trends in Outpatient Quality Indicators

描述：尽管越来越多的关注医疗保健质量 美国的进步，全国门诊医疗质量 服务没有得到评估。尤其缺乏严格的评估 少数种族和族裔门诊护理质量的趋势。 本申请将使用1992-2001年的数据来解决这个问题 国家门诊医疗调查（NAMCS）和国家医院 门诊医疗调查（NHAMCS）。它的目标是：1）构建一个集合 门诊质量指标，2）评估护理质量在国家 3）评估这些指标的时间趋势， 指标，以及4）确定患者，医生和组织的预测 护理质量，特别关注种族/族裔少数群体。一组 27项拟议的质量指标将提供定量评估， 质量和将涵盖：1）推荐的药物（例如，心房华法林 纤维性颤动），2）抗生素使用（例如，抗生素在病毒性呼吸道疾病中的应用 感染），3）医生咨询/疾病管理（例如，膳食 糖尿病咨询），4）诊断测试（例如，筛查尿分析 测试），和5）用药错误（例如，危险的药物-药物相互作用）。

DESCRIPTION: Despite the increasing attention on health care quality improvement in the U.S., the national quality of outpatient health care services has not been assessed. Particularly lacking are rigorous evaluations of trends in the quality of outpatient care for racial and ethnic minorities. This application will address this issue using data from the 1992-2001 National Ambulatory Medical Care Surveys (NAMCS) and National Hospital Ambulatory Medical Care Surveys (NHAMCS). Its aims are to: 1) construct a set of outpatient quality indicators, 2) assess quality of care at the national level using the selected indicators, 3) evaluate time trends in these indicators, and 4) determine patient, physician and organizational predictors of quality of care, with a particular focus on racial/ethnic minorities. A set of 27 proposed quality indicators will provide a quantitative assessment of quality and will cover: 1) recommended medications (e.g., warfarin in atrial fibrillation), 2) antibiotic use (e.g., antibiotics in viral respiratory infections), 3) physician counseling/disease management (e.g., dietary counseling in diabetes), 4) diagnostic testing (e.g., screening urinalysis tests), and 5) medication errors (e.g., risky drug-drug interactions).